H1B Report
Side-by-side comparison

Microsoft Corporation vs Mylan Pharmaceuticals, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Microsoft Corporation
WARank #6FEIN 91-1144442
Entity B
Mylan Pharmaceuticals, Inc.
PARank #FEIN 55-0455423

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricMicrosoft CorporationMylan Pharmaceuticals, Inc.
Total filings70,316132
Certified %94.15%79.55%
Denied %0.12%1.52%
Withdrawn %0.71%2.27%
Cert-withdrawn %5.02%16.67%
Rank#6
Active yearsFY2010–FY2026FY2010–FY2025
Worksite stateWAPA

Outcomes — Microsoft Corporation

DOL case-status mix.

Outcome breakdown: Certified 94.2%, Cert-withdrawn 5.0%, Withdrawn 0.7%, Denied 0.1%
Outcome breakdown
OutcomeShare
Certified94.2%
Cert-withdrawn5.0%
Withdrawn0.7%
Denied0.1%
Certified94.2%
Cert-withdrawn5.0%
Withdrawn0.7%
Denied0.1%

Outcomes — Mylan Pharmaceuticals, Inc.

DOL case-status mix.

Outcome breakdown: Certified 79.5%, Cert-withdrawn 16.7%, Withdrawn 2.3%, Denied 1.5%
Outcome breakdown
OutcomeShare
Certified79.5%
Cert-withdrawn16.7%
Withdrawn2.3%
Denied1.5%
Certified79.5%
Cert-withdrawn16.7%
Withdrawn2.3%
Denied1.5%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Microsoft Corporation
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104,390
FY20114,184
FY20123,943
FY20133,813
FY20143,637
FY20154,452
FY20164,888
FY20174,806
FY20185,438
FY20195,916
FY202051
FY2021110
FY2022150
FY20232,791
FY20249,492
FY20259,362
FY20262,893
Mylan Pharmaceuticals, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104
FY201111
FY20126
FY201314
FY201417
FY201514
FY201620
FY201712
FY201815
FY201913
FY20200
FY20211
FY20220
FY20231
FY20241
FY20253
FY20260

Top 5 occupations — Microsoft Corporation

Top 5 occupations — Mylan Pharmaceuticals, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.